lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent
Scope Note
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
Entry Term(s)
Tumour Lysis Syndrome
Previous Indexing
Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988)
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
